Iohexol: Clinical Trials

9 trials of Iohexol, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

9 completed. 9 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 49Completed 9

Follow Iohexol: new trials by email Literature Review of Iohexol trials Research Report on Iohexol

Trials (filtered) newest first · largest first

All 9 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Optimization of Beta-lactam Dosing in Critically Ill Patients With Cystatin C (OPTIMIZE-GNI)
Iohexol - Bacterial Infection
Phase 4CompletedNational Institute of Allergy and Infectious Diseases (NIAID)1612025-02-122026-07-31
Iso-Osmolar vs. Low-Osmolar Contrast Agents for Optical Coherence Tomography
Iodixanol, Iohexol - Coronary Artery Disease, Contrast Media Reaction
Phase 4CompletedMinneapolis Heart Institute Foundation622021-09-302026-08-19
Mechanisms Underlying Hypotensive Response to ARB/NEP Inhibition - Aim 3
LCZ 696, Placebo, Para-aminohippurate - Heart Failure
Phase 4CompletedYale University462021-05-272026-10-27
Renal Effects of Hormones/Biomarkers in Transgender PrEP Recipients
IHX-CL measurements, Iohexol - Transgender, Renal Function
Phase 4CompletedUniversity of California, San Diego422020-09-172022-03-03
Mechanisms Underlying Hypotensive Response to ARB/NEP Inhibition - Aim 2
LCZ 696, Icatibant, placebo - Heart Failure
Phase 4CompletedVanderbilt University Medical Center462019-11-012026-08-11
Dosing Iodinated Contrast Media According to Lean vs. Total Body Weight
Iohexol - Contrast Media Dosing
Phase 4CompletedNova Scotia Health Authority2392018-02-212019-01-31
Renal Effect of Stribild or Other Tenofovir DF-containing Regimens Compared to Ritonavir-boosted Atazanavir Plus Abacavir/Lamivudine in Antiretroviral Treatment-naive HIV-1 Infected Adults
STB, TVD, ATR - HIV-1 Infection
Phase 4CompletedGilead Sciences722014-12-152018-01-03
Measurement of Glomerular Filtration Rate (GFR) in HIV Patients: Single-center Study Comparing the Accuracy of Estimators of GFR Versus Iohexol Plasma Clearance
iohexol - HIV
Phase 4CompletedCentre Hospitalier Universitaire de Saint Etienne3002011-02-012016-03-10
Omnipaque Versus Gastroview as Oral Contrast for Abdominal and Pelvic CT
Omnipaque, Gastroview - Healthy
Phase 4CompletedUniversity of Alabama at Birmingham3002007-08-012017-04-18

Conditions studied

Heart Failure (2)  ·  Bacterial Infections (1)  ·  Coronary Artery Disease (1)

Sponsors

Centre Hospitalier Universitaire de Saint Etienne (1)  ·  Gilead Sciences (1)  ·  Minneapolis Heart Institute Foundation (1)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (1)  ·  Nova Scotia Health Authority (1)  ·  University of Alabama at Birmingham (1)  ·  University of California, San Diego (1)  ·  Vanderbilt University Medical Center (1)  ·  Yale University (1)

Countries

United States (6)  ·  France (2)  ·  Belgium (1)  ·  Canada (1)  ·  Ireland (1)  ·  Spain (1)  ·  United Kingdom (1)

Top investigators

Andreu Costa, Md FRCPC (1)  ·  Emmanouil Brilakis, MD, PhD (1)  ·  Michelle McNamara, MD (1)  ·  Nancy J. Brown, M.D. (1)  ·  Nancy J. Brown, MD (1)  ·  Nimish Patel, PharmD (1)

Results publications

PMID 31439467, PMID 42028604

NIH funding

2014 (1), 5UM1AI104681-12 (1)